Medicare Enrolled
Dr. Rini Palathingal, MD
Hematology & Oncology · Jersey, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Palathingal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Palathingal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Palathingal
Dr. Rini Palathingal is a hematology & oncology specialist in Jersey, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Palathingal performed 1,372 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Palathingal received a total of $14,023 from 69 pharmaceutical and/or device companies across 777 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Palathingal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ 1,372 Medicare services
$14,023 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,372
Medicare services
Bottom 43% in NJ for hematology & oncology
Not available
Unique patients (not deduplicated)
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
674 | $105 | $240 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
346 | $8 | $30 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
104 | $12 | $70 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
82 | $156 | $325 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
54 | $1 | $5 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
40 | $144 | $365 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
33 | $5 | $5 |
| New patient office visit, complex (60-74 min) | 22 | $185 | $460 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
17 | $80 | $165 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$14,023
Total received (2018-2024)
Avg $2,003/year across 7 years
Top 21% in NJ for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
777
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,057
2023
$2,842
2022
$2,466
2021
$2,197
2020
$1,299
2019
$1,105
2018
$57
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$1,242
E.R. Squibb & Sons, L.L.C.
$347
AstraZeneca Pharmaceuticals LP
$285
PFIZER INC.
$279
Merck Sharp & Dohme LLC
$224
Daiichi Sankyo Inc.
$142
Bayer Healthcare Pharmaceuticals Inc.
$123
Tempus AI, Inc
$116
Mirati Therapeutics, Inc.
$103
Takeda Pharmaceuticals U.S.A., Inc.
$98
Celgene Corporation
$95
HOLOGIC INC
$93
Gilead Sciences, Inc.
$74
Janssen Biotech, Inc.
$74
BeiGene USA, Inc.
$73
Eisai Inc.
$72
Incyte Corporation
$70
Genentech USA, Inc.
$61
Pharmacosmos Therapeutics Inc.
$42
Regeneron Healthcare Solutions, Inc.
$38
GlaxoSmithKline, LLC.
$38
Emmaus Medical, Inc.
$38
Lilly USA, LLC
$36
Exelixis Inc.
$36
Genmab U.S., Inc.
$34
ABBVIE INC.
$33
PharmaEssentia USA Corporation
$32
TerSera Therapeutics LLC
$29
Rigel Pharmaceuticals, Inc.
$24
Agios Pharmaceuticals, Inc.
$21
ARRAY BIOPHARMA INC
$19
Adaptive Biotechnologies Corporation
$18
TAIHO ONCOLOGY, INC.
$18
JAZZ PHARMACEUTICALS INC.
$16
RECORDATI_RARE_DISEASES_INC.
$15
Top 3 companies account for 46.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$2,311
AstraZeneca Pharmaceuticals LP
$1,261
E.R. Squibb & Sons, L.L.C.
$1,028
Incyte Corporation
$750
Janssen Biotech, Inc.
$672
PFIZER INC.
$668
Merck Sharp & Dohme LLC
$633
Astellas Pharma US Inc
$583
Amgen Inc.
$426
Daiichi Sankyo Inc.
$381
Celgene Corporation
$359
Takeda Pharmaceuticals U.S.A., Inc.
$323
Seagen Inc.
$321
Merck Sharp & Dohme Corporation
$289
Lilly USA, LLC
$284
BeiGene USA, Inc.
$259
Mirati Therapeutics, Inc.
$239
Bayer Healthcare Pharmaceuticals Inc.
$206
Eisai Inc.
$175
GlaxoSmithKline, LLC.
$175
Kite Pharma, Inc.
$158
Myriad Genetic Laboratories, Inc.
$147
Regeneron Healthcare Solutions, Inc.
$128
Tempus AI, Inc
$116
Genentech USA, Inc.
$107
Adaptive Biotechnologies Corporation
$106
Bayer HealthCare Pharmaceuticals Inc.
$104
Boehringer Ingelheim Pharmaceuticals, Inc.
$98
HOLOGIC INC
$93
Gilead Sciences, Inc.
$86
Pharmacyclics LLC, An AbbVie Company
$86
Exelixis Inc.
$85
EISAI INC.
$79
Global Blood Therapeutics, Inc.
$75
Myovant Sciences Inc.
$75
GENZYME CORPORATION
$74
GE HealthCare
$73
Rigel Pharmaceuticals, Inc.
$69
Emmaus Medical, Inc.
$63
ARRAY BIOPHARMA INC
$60
CTI BioPharma Corp.
$58
EMD Serono, Inc.
$57
Sumitomo Pharma America, Inc.
$54
Genmab U.S., Inc.
$51
GE HEALTHCARE
$47
Pharmacosmos Therapeutics Inc.
$42
Heron Therapeutics, Inc.
$39
ABBVIE INC.
$33
Blueprint Medicines Corporation
$32
PharmaEssentia USA Corporation
$32
Deciphera Pharmaceuticals Inc.
$31
RECORDATI_RARE_DISEASES_INC.
$29
TerSera Therapeutics LLC
$29
Aveo Pharmaceuticals, Inc.
$23
Agios Pharmaceuticals, Inc.
$21
AVEO Pharmaceuticals, Inc.
$21
Novocure Inc.
$20
Puma Biotechnology, Inc.
$20
MACROGENICS, INC.
$19
TAIHO ONCOLOGY, INC.
$18
Flowonix Medical Incorporated
$18
JAZZ PHARMACEUTICALS INC.
$16
Coherus Biosciences Inc.
$15
Taiho Oncology, Inc.
$15
Servier Pharmaceuticals LLC
$13
TG THERAPEUTICS, INC.
$13
Pharmacyclics LLC, an AbbVie Company
$12
Sobi, Inc
$12
Sun Pharmaceutical Industries Inc.
$11
Top 3 companies account for 32.8% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALUNBRIG · AYVAKIT · Alecensa · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABOMETYX · CALQUENCE · CHANTIX · CINVANTI · COSELA · Columvi · DARZALEX · DOPTELET · ELAHERE · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EVENITY · EXKIVITY · Endari · Enhertu · FOTIVDA · FRUZAQLA · Fabhalta · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Localizer · MARGENZA · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · NINLARO · Nerlynx · Nplate · Nubeqa · ODOMZO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · PADCEV · PIQRAY · PLUVICTO · PRECISETUMOR · PROMACTA · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · Prometra II · QINLOCK · REBLOZYL · RETEVMO · Reblozyl · Rezlidhia · SANDOSTATIN · SCEMBLIX · SHINGRIX · SPRYCEL · SUTENT · SYLVANT · Stivarga · Sustol · TABRECTA · TAGRISSO · TASIGNA · TECVAYLI · TIBSOVO · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tivdak · UKONIQ · Udenyca · VERZENIO · VOTRIENT · Vectibix · Venclexta · Vonjo · XALKORI · XGEVA · XTANDI · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
733
County median income
$90,032
Nearest hospital to ZIP centroid (approximate)
CAREPOINT HEALTH-CHRIST HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Palathingal is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Palathingal experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Palathingal performed 674 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Palathingal receive payments from pharmaceutical companies?
Yes. Dr. Palathingal received a total of $14,023 from 69 companies across 777 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Palathingal's costs compare to other hematology & oncology specialists in Jersey?
Dr. Palathingal's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Palathingal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Jersey
Browse hematology & oncology specialists in Jersey ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NJ
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NJ
Which NJ hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology